Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brooke Hayward

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis and Related Disorders|June 21, 2023
Comparative effectiveness of cladribine tablets versus fingolimod in the treatment of highly active multiple sclerosis: A real-world studyWallace J Brownlee, Aiden Haghikia, Brooke Hayward, et al.
Reproductive Biomedicine Online|April 9, 2024
Effectiveness of recombinant human FSH: recombinant human LH combination treatment versus recombinant human FSH alone for assisted reproductive technology in women aged 35-40 yearsAlexandra P Bielfeld, Juan-Enrique Schwarze, Patrice Verpillat, et al.
Therapeutic Advances in Neurological Disorders|May 6, 2015
A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosisRobert Zivadinov, Michael Dwyer, Silva Markovic-Plese, et al.
Neurodegenerative Disease Management|February 1, 2021
CLICK-MS and MASTER-2 Phase IV trial design: cladribine tablets in suboptimally controlled relapsing multiple sclerosisAugusto A Miravalle, Joshua Katz, Derrick Robertson, et al.
Journal of Neuroimmunology|April 14, 2015
Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24 weeks of therapy with subcutaneous interferon beta-1a three times weeklyMichael G Dwyer, Robert Zivadinov, Silva Markovic-Plese, et al.
Plos One|March 15, 2014
Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot studyRobert Zivadinov, Michael G Dwyer, Silva Markovic-Plese, et al.
AIDS Research and Human Retroviruses|March 14, 2024
Incident HIV-Associated Wasting/Low Weight Is Associated with Nearly Doubled Mortality Risk in the Modern ART EraMichael B Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, et al.
AIDS Research and Human Retroviruses|July 25, 2023
Definition, Burden, and Predictors of HIV-Associated Wasting and Low Weight in the OPERA CohortMichael B Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 25, 2015
Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MSYazhong Tao, Xin Zhang, Robert Zivadinov, et al.
BMC Neurology|November 13, 2015
Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trialMichael G Dwyer, Robert Zivadinov, Yazhong Tao, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|June 21, 2023
Comparative effectiveness of cladribine tablets versus fingolimod in the treatment of highly active multiple sclerosis: A real-world studyWallace J Brownlee, Aiden Haghikia, Brooke Hayward, et al.
Reproductive Biomedicine Online|April 9, 2024
Effectiveness of recombinant human FSH: recombinant human LH combination treatment versus recombinant human FSH alone for assisted reproductive technology in women aged 35-40 yearsAlexandra P Bielfeld, Juan-Enrique Schwarze, Patrice Verpillat, et al.
Therapeutic Advances in Neurological Disorders|May 6, 2015
A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosisRobert Zivadinov, Michael Dwyer, Silva Markovic-Plese, et al.
Neurodegenerative Disease Management|February 1, 2021
CLICK-MS and MASTER-2 Phase IV trial design: cladribine tablets in suboptimally controlled relapsing multiple sclerosisAugusto A Miravalle, Joshua Katz, Derrick Robertson, et al.
Journal of Neuroimmunology|April 14, 2015
Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24 weeks of therapy with subcutaneous interferon beta-1a three times weeklyMichael G Dwyer, Robert Zivadinov, Silva Markovic-Plese, et al.
Plos One|March 15, 2014
Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot studyRobert Zivadinov, Michael G Dwyer, Silva Markovic-Plese, et al.
AIDS Research and Human Retroviruses|March 14, 2024
Incident HIV-Associated Wasting/Low Weight Is Associated with Nearly Doubled Mortality Risk in the Modern ART EraMichael B Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, et al.
AIDS Research and Human Retroviruses|July 25, 2023
Definition, Burden, and Predictors of HIV-Associated Wasting and Low Weight in the OPERA CohortMichael B Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 25, 2015
Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MSYazhong Tao, Xin Zhang, Robert Zivadinov, et al.
BMC Neurology|November 13, 2015
Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trialMichael G Dwyer, Robert Zivadinov, Yazhong Tao, et al.
Pageof 5